# Efficacy and Safety of Midodrine and Atomoxetine for Neurogenic OH

> **NCT03350659** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 50 (actual)

## Conditions studied

- Neurogenic Orthostatic Hypotension

## Interventions

- **DRUG:** Midodrine
- **DRUG:** Atomoxetine

## Key facts

- **NCT ID:** NCT03350659
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2019-01-29
- **Final completion:** 2019-03-15
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-04-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03350659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03350659, "Efficacy and Safety of Midodrine and Atomoxetine for Neurogenic OH". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03350659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*